Rani Therapeutics Holdings (RANI) Net Equity Issued and Repurchased (2021 - 2026)
Rani Therapeutics Holdings' Net Equity Issued and Repurchased was $18.69 million in Q2 2026, up 379.9% from $3.9 million a year earlier.
Powered by 
Analysis
Rani Therapeutics Holdings (RANI) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Rani Therapeutics Holdings' Net Equity Issued and Repurchased was $14.77 million through Jun 30, 2026, up 15.7% year-over-year; for FY2025, it was $12,000, down 76.5% from FY2024.
- Net Equity Issued and Repurchased shows a four-year compound annual growth rate of -88.7% (FY2021 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $51,000 in FY2024 (+27.5%), $40,000 in FY2023 (-13.0%), $46,000 in FY2022 (-99.9%) and $73.65 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2021.
- Per Business Quant data, RANI's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $5,000 (Q1 2026), -$3.86 million (Q4 2025) and -$68,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Rani Therapeutics Holdings | 147.86 Mn | 156.61 Mn | - | 18.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.69 Mn |
| Mar 31, 2026 | 5,000.00 |
| Dec 31, 2025 | -3.86 Mn |
| Sep 30, 2025 | -68,000.00 |
| Jun 30, 2025 | 3.90 Mn |
| Mar 31, 2025 | 42,000.00 |
| Dec 31, 2024 | -48,000.00 |
| Sep 30, 2024 | 8.88 Mn |
| Jun 30, 2024 | -83,000.00 |
| Mar 31, 2024 | 121,000.00 |
| Dec 31, 2023 | -40,000.00 |
| Sep 30, 2023 | 78,000.00 |
| Jun 30, 2023 | -130,000.00 |
| Mar 31, 2023 | 132,000.00 |
| Dec 31, 2022 | -148,000.00 |
| Sep 30, 2022 | 145,000.00 |
| Jun 30, 2022 | 49,000.00 |
| Dec 31, 2021 | -570,000.00 |
| Sep 30, 2021 | 74.21 Mn |
| Mar 31, 2021 | 13,000.00 |
API Access
Rani Therapeutics Holdings Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RANI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "RANI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=RANI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();